
William G. Wright
Examiner (ID: 13821)
| Most Active Art Unit | 1106 |
| Art Unit(s) | 1106, 1754 |
| Total Applications | 637 |
| Issued Applications | 554 |
| Pending Applications | 0 |
| Abandoned Applications | 83 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 10574060
[patent_doc_number] => 09296687
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-03-29
[patent_title] => 'Modulators of HSP70/DnaK function and methods of use thereof'
[patent_app_type] => utility
[patent_app_number] => 14/048540
[patent_app_country] => US
[patent_app_date] => 2013-10-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 54
[patent_figures_cnt] => 37
[patent_no_of_words] => 26225
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14048540
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/048540 | Modulators of HSP70/DnaK function and methods of use thereof | Oct 7, 2013 | Issued |
Array
(
[id] => 9409031
[patent_doc_number] => 20140100283
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-04-10
[patent_title] => 'Method to Increase Absorption and Bioavailability of Oral Glutathione'
[patent_app_type] => utility
[patent_app_number] => 14/047645
[patent_app_country] => US
[patent_app_date] => 2013-10-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1874
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14047645
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/047645 | Method to Increase Absorption and Bioavailability of Oral Glutathione | Oct 6, 2013 | Abandoned |
Array
(
[id] => 10209301
[patent_doc_number] => 20150094291
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-04-02
[patent_title] => 'Method and Substance for Improving the Emotional Development of an Infant'
[patent_app_type] => utility
[patent_app_number] => 14/044379
[patent_app_country] => US
[patent_app_date] => 2013-10-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 2373
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14044379
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/044379 | Method and Substance for Improving the Emotional Development of an Infant | Oct 1, 2013 | Abandoned |
Array
(
[id] => 9384704
[patent_doc_number] => 20140088186
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-03-27
[patent_title] => 'COMPOSITION CONTAINING ARYLNAPHTHALENE LIGNAN DERIVATIVE FOR PREVENTING AND/OR TREATING DEMENTIA'
[patent_app_type] => utility
[patent_app_number] => 14/036810
[patent_app_country] => US
[patent_app_date] => 2013-09-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 11214
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14036810
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/036810 | Composition containing arylnaphthalene lignan derivative for preventing and/or treating dementia | Sep 24, 2013 | Issued |
Array
(
[id] => 9269913
[patent_doc_number] => 20140024831
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-01-23
[patent_title] => '4\'-DEMETHYLEPIPODOPHYLLOTOXIN DERIVATIVE, PREPARATION METHOD AND USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/036443
[patent_app_country] => US
[patent_app_date] => 2013-09-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 6122
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14036443
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/036443 | 4′-demethylepipodophyllotoxin derivative, preparation method and use thereof | Sep 24, 2013 | Issued |
Array
(
[id] => 9269770
[patent_doc_number] => 20140024688
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-01-23
[patent_title] => 'Potentiated Biocidal Compositions and Methods of Use'
[patent_app_type] => utility
[patent_app_number] => 14/032755
[patent_app_country] => US
[patent_app_date] => 2013-09-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 14939
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14032755
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/032755 | Potentiated Biocidal Compositions and Methods of Use | Sep 19, 2013 | Abandoned |
Array
(
[id] => 9932276
[patent_doc_number] => 20150080468
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-03-19
[patent_title] => 'COMPOSITION AND METHOD FOR PROCESSING AND DELIVERING BIOAVAILABLE METHIONINE ANALOGS, DERIVATIVES, AND PRECURSORS, THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/026199
[patent_app_country] => US
[patent_app_date] => 2013-09-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 5645
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14026199
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/026199 | COMPOSITION AND METHOD FOR PROCESSING AND DELIVERING BIOAVAILABLE METHIONINE ANALOGS, DERIVATIVES, AND PRECURSORS, THEREOF | Sep 12, 2013 | Abandoned |
Array
(
[id] => 10095892
[patent_doc_number] => 09132188
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-09-15
[patent_title] => 'Chemically Programmed Vaccination'
[patent_app_type] => utility
[patent_app_number] => 14/010201
[patent_app_country] => US
[patent_app_date] => 2013-08-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 37
[patent_no_of_words] => 16443
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 5
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14010201
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/010201 | Chemically Programmed Vaccination | Aug 25, 2013 | Issued |
Array
(
[id] => 10220355
[patent_doc_number] => 20150105349
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-04-16
[patent_title] => '(R)-(-)-1,2-propanediol compositions and methods'
[patent_app_type] => utility
[patent_app_number] => 13/987657
[patent_app_country] => US
[patent_app_date] => 2013-08-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 8185
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13987657
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/987657 | (R)-(-)-1,2-propanediol compositions and methods | Aug 18, 2013 | Abandoned |
Array
(
[id] => 11793131
[patent_doc_number] => 09402821
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-08-02
[patent_title] => 'Methods and pharmaceutical compositions for treatment of cystic fibrosis'
[patent_app_type] => utility
[patent_app_number] => 14/421541
[patent_app_country] => US
[patent_app_date] => 2013-08-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 10320
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14421541
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/421541 | Methods and pharmaceutical compositions for treatment of cystic fibrosis | Aug 12, 2013 | Issued |
Array
(
[id] => 9192052
[patent_doc_number] => 20130331368
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-12-12
[patent_title] => 'METHOD OF TREATING HEPATOCELLULAR CARCINOMA'
[patent_app_type] => utility
[patent_app_number] => 13/964287
[patent_app_country] => US
[patent_app_date] => 2013-08-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 4774
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13964287
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/964287 | METHOD OF TREATING HEPATOCELLULAR CARCINOMA | Aug 11, 2013 | Abandoned |
Array
(
[id] => 9307134
[patent_doc_number] => 20140045808
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-02-13
[patent_title] => 'Reducing Risk of Contracting Clostridium-Difficile Associated Disease'
[patent_app_type] => utility
[patent_app_number] => 13/962658
[patent_app_country] => US
[patent_app_date] => 2013-08-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 17608
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13962658
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/962658 | Reducing risk of contracting Clostridium-difficile associated disease | Aug 7, 2013 | Issued |
Array
(
[id] => 9643382
[patent_doc_number] => 20140221494
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-08-07
[patent_title] => 'MEDICAMENT'
[patent_app_type] => utility
[patent_app_number] => 13/958069
[patent_app_country] => US
[patent_app_date] => 2013-08-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 4681
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13958069
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/958069 | MEDICAMENT | Aug 1, 2013 | Abandoned |
Array
(
[id] => 9422566
[patent_doc_number] => 20140107217
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-04-17
[patent_title] => 'SYNTHESIS AND GROWTH REGULATORY ACTIVITY OF A PROTOTYPE MEMBER OF A NEW FAMILY OF AMlNOTHIOL RADIOPROTECTORS'
[patent_app_type] => utility
[patent_app_number] => 13/957188
[patent_app_country] => US
[patent_app_date] => 2013-08-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 3524
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13957188
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/957188 | Synthesis and growth regulatory activity of a prototype member of a new family of aminothiol radioprotectors | Jul 31, 2013 | Issued |
Array
(
[id] => 9198886
[patent_doc_number] => 20130338201
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-12-19
[patent_title] => 'Method of Cancer Treatment with 2-(1H-Indole-3-Carbonyl)-Thiazole-4-Carboxylic Acid Methyl Ester'
[patent_app_type] => utility
[patent_app_number] => 13/954834
[patent_app_country] => US
[patent_app_date] => 2013-07-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 10068
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13954834
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/954834 | Method of Cancer Treatment with 2-(1H-Indole-3-Carbonyl)-Thiazole-4-Carboxylic Acid Methyl Ester | Jul 29, 2013 | Abandoned |
Array
(
[id] => 9281420
[patent_doc_number] => 20140031388
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-01-30
[patent_title] => 'AKT INACTIVATION BY TOCOPHERYL DERIVATIVES'
[patent_app_type] => utility
[patent_app_number] => 13/952032
[patent_app_country] => US
[patent_app_date] => 2013-07-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 17699
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13952032
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/952032 | AKT INACTIVATION BY TOCOPHERYL DERIVATIVES | Jul 25, 2013 | Abandoned |
Array
(
[id] => 9602579
[patent_doc_number] => 20140199261
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-07-17
[patent_title] => 'METHOD OF REDUCING MULTI-DRUG RESISTANCE USING INOSITOL TRIPYROPHOSPHATE'
[patent_app_type] => utility
[patent_app_number] => 13/950998
[patent_app_country] => US
[patent_app_date] => 2013-07-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 9904
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13950998
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/950998 | METHOD OF REDUCING MULTI-DRUG RESISTANCE USING INOSITOL TRIPYROPHOSPHATE | Jul 24, 2013 | Abandoned |
Array
(
[id] => 10838044
[patent_doc_number] => 08865717
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-10-21
[patent_title] => 'Heterocyclic compounds'
[patent_app_type] => utility
[patent_app_number] => 13/944000
[patent_app_country] => US
[patent_app_date] => 2013-07-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 35727
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13944000
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/944000 | Heterocyclic compounds | Jul 16, 2013 | Issued |
Array
(
[id] => 9384636
[patent_doc_number] => 20140088118
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-03-27
[patent_title] => 'HETEROCYCLIC COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 13/944042
[patent_app_country] => US
[patent_app_date] => 2013-07-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 35724
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13944042
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/944042 | Heterocyclic compounds | Jul 16, 2013 | Issued |
Array
(
[id] => 9281359
[patent_doc_number] => 20140031327
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-01-30
[patent_title] => 'NON-SURGICAL METHOD OF TREATMENT FOR CATARACT'
[patent_app_type] => utility
[patent_app_number] => 13/944477
[patent_app_country] => US
[patent_app_date] => 2013-07-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9504
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13944477
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/944477 | Non-surgical method of treatment for cataract | Jul 16, 2013 | Issued |